Viking Therapeutics Inc (NASDAQ: VKTX) is -40.18% lower on its value in year-to-date trading and has touched a low of $18.92 and a high of $81.73 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VKTX stock was last observed hovering at around $27.51 in the last trading session, with the day’s gains setting it 2.68%.
Currently trading at $30.19, the stock is 10.51% and 10.02% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.95 million and changing 9.74% at the moment leaves the stock -23.55% off its SMA200. VKTX registered -24.98% loss for a year compared to 6-month loss of -26.58%. The firm has a 50-day simple moving average (SMA 50) of $27.4396 and a 200-day simple moving average (SMA200) of $39.492176.
The stock witnessed a 11.65% gain in the last 1 month and extending the period to 3 months gives it a 33.47%, and is 13.92% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.60% over the week and 6.30% over the month.
Viking Therapeutics Inc (VKTX) has around 36 employees, a market worth around $3.39B and $0.00M in sales. Distance from 52-week low is 59.57% and -63.06% from its 52-week high. The company has generated returns on investments over the last 12 months (-15.13%).
The EPS is expected to shrink by -86.96% this year.
Viking Therapeutics Inc (VKTX) Top Institutional Holders
499.0 institutions hold shares in Viking Therapeutics Inc (VKTX), with institutional investors hold 71.56% of the company’s shares. The shares outstanding are 112.29M, and float is at 108.96M with Short Float at 26.13%. Institutions hold 70.04% of the Float.
The top institutional shareholder in the company is FMR LLC with over 16.54 million shares valued at $876.8 million. The investor’s holdings represent 14.9835% of the VKTX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 10.1 million shares valued at $535.26 million to account for 9.147 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 6.03 million shares representing 5.4589% and valued at over $319.45 million, while STATE STREET CORP holds 4.6403 of the shares totaling 5.12 million with a market value of $271.54 million.
Viking Therapeutics Inc (VKTX) Insider Activity
The most recent transaction is an insider sale by Lian Brian,the company’sPresident & CEO. SEC filings show that Lian Brian sold 26,889 shares of the company’s common stock on Jul 03 ’25 at a price of $27.80 per share for a total of $0.75 million. Following the sale, the insider now owns 2.39 million shares.
Viking Therapeutics Inc disclosed in a document filed with the SEC on Jul 03 ’25 that ZANTE GREG (Chief Financial Officer) sold a total of 4,266 shares of the company’s common stock. The trade occurred on Jul 03 ’25 and was made at $27.76 per share for $0.12 million. Following the transaction, the insider now directly holds 0.17 million shares of the VKTX stock.
Still, SEC filings show that on Jul 03 ’25, Mancini Marianna (Chief Operating Officer) disposed off 4,266 shares at an average price of $27.77 for $0.12 million. The insider now directly holds 377,535 shares of Viking Therapeutics Inc (VKTX).
